Document is current

Any future updates will be listed below

Correction to: Rozanolixizumab: First Approval

Crossref DOI link: https://doi.org/10.1007/s40265-023-01960-y

Published Online: 2023-10-20

Published Print: 2023-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark